<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04126174</url>
  </required_header>
  <id_info>
    <org_study_id>CB-19-001</org_study_id>
    <nct_id>NCT04126174</nct_id>
  </id_info>
  <brief_title>Femtosecond Laser-assisted Arcuate Incisions Versus Manual Arcuate Incisions Outcomes</brief_title>
  <official_title>Femtosecond Laser-assisted Arcuate Incisions Versus Manual Arcuate Incisions Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gainesville Eye Associates</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Science in Vision</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Gainesville Eye Associates</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to compare the effectiveness of LenSx laser arcuate relaxing incisions
      vs. manual (blade) arcuate relaxing incisions in patients with low, but significant, levels
      of astigmatism.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a comparative, prospective, randomized contralateral eye study of visual
      outcomes after LenSx laser arcuate relaxing incisions utilizing the Woodcock nomogram at 90%
      thickness vs. manual (blade) fixed keratome diamond knife at 600 microns for arcuate relaxing
      incisions utilizing the Donnenfeld nomogram. Subjects will be assessed pre-operatively and at
      1 day, 1 month and 3 months post-operatively. Clinical evaluations will include measurement
      of visual acuity, manifest refraction and corneal astigmatism measurement with the Lenstar
      and slit lamp exam.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">October 15, 2019</start_date>
  <completion_date type="Anticipated">August 2020</completion_date>
  <primary_completion_date type="Anticipated">August 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Contralateral eye study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Residual refractive astigmatism</measure>
    <time_frame>3 months</time_frame>
    <description>Residual refractive astigmatism</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of eyes with residual refractive astigmatism &lt; 0.50 diopters (D)</measure>
    <time_frame>3 months</time_frame>
    <description>Percentage of eyes with residual refractive astigmatism &lt; 0.50 diopters (D)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Uncorrected monocular distance visual acuity</measure>
    <time_frame>3 months</time_frame>
    <description>Uncorrected monocular distance visual acuity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spherical equivalent refraction</measure>
    <time_frame>3 months</time_frame>
    <description>Spherical equivalent refraction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Corneal astigmatism</measure>
    <time_frame>3 months</time_frame>
    <description>Corneal astigmatism</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">41</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>Femtosecond limbal relaxing incision (LRI)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Eyes will be treated with arcuate incisions from a femtosecond laser system.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Manual LRI</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Eyes will be treated with arcuate incisions completed manually with a blade.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>femtosecond laser system arcuate corneal incision</intervention_name>
    <description>Corneal arcuate incision made either with a blade (manual) or femtosecond laser system.</description>
    <arm_group_label>Femtosecond limbal relaxing incision (LRI)</arm_group_label>
    <other_name>LRI</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Manual LRI</intervention_name>
    <description>Manual LRI</description>
    <arm_group_label>Manual LRI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

        Subjects are eligible for the study if they meet the following criteria:

        Note: Ocular criteria must be met in both eyes.

          -  are willing and able to understand and sign an informed consent;

          -  are willing and able to attend all study visits;

          -  are more than 40 years of age, of either gender and any race;

          -  are presenting for cataract surgery or refractive lens exchange with a desire to
             reduce astigmatism and will be implanted with a non-toric lens

          -  have good ocular health, with no pathology that compromises visual acuity (outside of
             residual refractive error and cataract)

          -  have 0.50 D to 1.75 D of regular corneal astigmatism

          -  have potential acuity of 20/25 or better

          -  Are scheduled to have a non-toric monofocal intraocular lens (IOL) (SN60WF) lens
             implanted in both eyes

        Exclusion Criteria If any of the following exclusion criteria are applicable to the subject
        or either eye, the subject should not be enrolled in the study.

          -  Irregular astigmatism (e.g. keratoconus)

          -  Corneal pathology (e.g. scar, dystrophy, pterygium, moderate-to-severe dry eye)

          -  Monocular status (e.g. amblyopia)

          -  Previous radial keratotomy, corneal refractive surgery or other corneal surgery (e.g.
             corneal transplant, lamellar keratoplasty)

          -  Previous anterior or posterior chamber surgery (e.g., vitrectomy, laser iridotomy)

          -  Diabetic retinopathy

          -  Macular pathology (e.g. age-related macular degeneration, epiretinal membrane)

          -  History of retinal detachment

          -  Subjects who have an acute or chronic disease or illness that would confound the
             results of this investigation (e.g., immunocompromised, connective tissue disease,
             clinically significant atopic disease, diabetes, and any other such disease or
             illness), that are known to affect post-operative visual acuity.

        Pregnancy has a known effect on the stability of refractions and visual acuity. As such,
        subjects who become pregnant during the study will not be discontinued but their data may
        be excluded from analyses of effectiveness.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Clayton G Blehm, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gainesville Eye Associates</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Gainesville Eye Associates</name>
      <address>
        <city>Gainesville</city>
        <state>Georgia</state>
        <zip>30501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 11, 2019</study_first_submitted>
  <study_first_submitted_qc>October 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 15, 2019</study_first_posted>
  <last_update_submitted>December 11, 2019</last_update_submitted>
  <last_update_submitted_qc>December 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>astigmatism, limbal relaxing incisions</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Surgical Wound</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

